Strumento inattivo

Altre lingue Tauriga Sciences, Inc.

Azioni

TAUG

US87669X2053

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Tauriga Sciences : Amendment to Late Filing Notice (Form NT 10-K/A)	14/07/22
FindThisBest Selects Tauri-Gum as The #1 Best Kosher Chewing Gum in the Overall Marketplace	13/05/22
Tauriga Sciences Inc. Chief Executive Officer Completes 1,500,000 Share Insider Purchase	09/05/22
Tauriga Sciences Inc. Receives its 10,000th E-Commerce Order	25/03/22
Tauriga Sciences Inc. Receives its 10,000th E-Commerce Order	25/03/22
Tauriga Sciences Inc. Invited to Participate in the Upcoming Kroger “Merchandising Planogram and Sales Planning” Event	10/03/22
TAURIGA SCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	16/02/22
Tauriga Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	16/02/22
Tauriga Sciences Inc. Receives its 9,000th E-Commerce Order	21/01/22
Tauriga Sciences Inc. Generates Record Quarterly Net Revenue, from Both Amazon and E-Commerce Business Segment	03/01/22
Tauriga Sciences Inc. Receives Product Endorsement From the State of Alaska	21/12/21
Tauriga Sciences Inc. Receives Product Endorsement from the State of Alaska	21/12/21
Tauriga Sciences Inc. Set to Report Record Quarterly Net Revenue	17/12/21
Tauriga Sciences Inc. Formally Submits its Clinical Study Protocol to the Institutional Review Board	17/12/21
Tauriga Sciences, Inc. Appoints Matthew A. Shaw as Member of Its Corporate Advisory Board	01/12/21
Tauriga Sciences, Inc. Appoints Matthew A. Shaw as Member of its Corporate Advisory Board	01/12/21
Tauriga Sciences : Announces Results of Special Meeting of Shareholders Held on November 22, 2021 - Form 8-K	23/11/21
TAURIGA SCIENCES, INC. : Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	23/11/21
Tauriga Sciences, Inc. Announces Results of Special Meeting of Shareholders Held on November 22, 2021	23/11/21
Clinical Validation is Completed for New COVID-19 Assay Designed by AEGEA Biotechnologies; Test Quantifies Viral Load to Determine Infection Level and Disease Progression	22/11/21

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Tauriga Sciences, Inc.

Azioni

TAUG

US87669X2053

Altre lingue

Filtri